News

Dr. Federica Bellerba, from European Institute of Oncology (IEO) will be presenting the abstract entitled: “Exploring mental health of students during the COVID-19 Pandemic: an international study within the EuCARE project” at the 32nd International Biometric Conference (IBC) 2024 in Atlanta, Georgia (USA). The International Biometric Conference is the bienal conference of the International Biometric […]

Anders Sönnerborg, a EuCARE partner from Karolinska Institute (KI) was present as symposium moderator in the prestigious meeting of the European Renal Association (ERA), one of the biggest nephrology associations worldwide and the largest in Europe. This meeting took place in Stockholm between 23-26th of May 2024. The symposium by AstraZeneca was about preparing for

We are delighted and honoured to have a symposium dedicated to the EuCARE project during ICAR 2024. The Italian Conference on Aids and Antiviral Research taking place in Rome from 19 to 21 June 2024. SARS-COV-2 and its continuous evolution still pose scientific questions and challenges, including those related to long-COVID. This pandemic highlighted the

EuCARE partners from ASST Santi Paolo were present at the 34th European Congress of Clinical Microbiology and Infectious Diseases 2024 in Barcelona Spain. Dr. Andrea Santoro from the ASST Santi Paolo e Carlo presented a poster entitled “Reduction of post COVID-19 condition during the Omicron wave: results from the EuCARE POSTCOVID Study” and was awarded

The 5thEdition of the European Mental Health awareness week took place between 13th and 19th of May 2024.This week is a pan-European initiative and is run by the non governmental organization (NGO) Mental Health Europe, the largest independent European mental health NGO. This week is important for bringing awareness about the importance of mental health

For the third consecutive year, the prestigious AREVIR meeting in Cologne, Germany, welcomed a dedicated session by EuCARE, marking yet another milestone in our collaborative efforts to combat infectious diseases. The session was brimming with lively exchanges of knowledge and innovative ideas, showcasing the remarkable progress achieved by the project across various fronts. Led by

We’re thrilled to share that EuCARE will be featured in a special session at the AREVIR Meeting 2024 for the third time! 🎉 Our team has the opportunity to showcase our latest research findings and collaborations in the fight against infectious diseases. From groundbreaking studies to impactful initiatives, EuCARE is committed to making a difference

🌟 EuCARE Surpasses 50,000 Patient Milestone! The EuCARE initiative has reached a significant milestone, enrolling over 50,000 patients across its clinical cohorts. These cohorts include the Hospitalised cohort, focusing on patients with COVID-19, and the Post-COVID cohort (PASC), investigating long-term sequelae of the virus. Enrollment status for clinical studies 🔬 Unprecedented Progress in Research: EuCARE

EuCARE partners made contributions to the Conference on Retroviruses and Opportunistic Infections 2024 (CROI), held from March 3rd to 6th, 2024. This prestigious conference, established in 1993, serves as a vital platform for basic scientists and clinical investigators to exchange insights into the epidemiology and biology of human retroviruses and associated diseases. Pontus Hegberg, a

On January 30, the first meeting of the Coordination Board, a COMECT (Coordination Mechanism for Cohorts and Trials) activity, was held, gathering together the Cohort Coordination Board (CCB) and the Trial Coordination Board (TCB). Representatives of the existing network and infrastructure were present, including the TCB Tx Pillar and the Vaccine Pillar. Among the discussion